MedTrace Logo

Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma Patients

NCT03839602 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2019-02-15

No results posted yet for this study

Summary

To analyze the long-term results and toxicities of the reducing clinical target volume (CTV) delineation method in early-stage nasopharyngeal carcinoma (NPC) patients treated with intensity modulated radiation therapy (IMRT).

Conditions

  • Target Volume Delineation
  • Early-stage Nasopharyngeal Carcinoma
  • Intensity Modulated Radiation Therapy

Interventions

RADIATION

Reducing CTV

CTVs were delineated in line with tumor stage, i.e. tumor invasion.

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-05-01
Primary Completion
2006-10-31
Completion
2018-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03839602 on ClinicalTrials.gov